Venous thromboembolism among Medicare acute ischaemic stroke patients with and without COVID-19

Xin Tong1, Quanhe Yang2, Ganesh Asaithambi3

  • 1Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA xtong@cdc.gov.

Insights

Patients with acute ischemic stroke (AIS) and a history of COVID-19 have a higher risk of venous thromboembolism (VTE). This increased VTE prevalence highlights the need for vigilant monitoring and prompt intervention in these vulnerable individuals.

Area of Science:

  • Cardiovascular Medicine
  • Infectious Diseases
  • Hematology

Background:

  • COVID-19 infection is linked to an elevated risk of venous thromboembolism (VTE).
  • Acute ischemic stroke (AIS) patients face a heightened risk of VTE.
  • The interplay between COVID-19 history and VTE risk in AIS patients requires further investigation.

Purpose of the Study:

  • To determine the prevalence of VTE in acute ischemic stroke (AIS) patients with and without a history of COVID-19.
  • To compare VTE rates between AIS patients with prior COVID-19 exposure and those without.
  • To quantify the association between COVID-19 history and VTE risk in AIS patients.

Main Methods:

  • Retrospective cohort study of Medicare fee-for-service (FFS) beneficiaries aged ≥65 years.
  • Inclusion of patients hospitalized for AIS between April 1, 2020, and March 31, 2022.
  • Comparison of VTE prevalence and adjusted prevalence ratios based on COVID-19 history.

Main Results:

  • VTE prevalence was 4.51% in AIS patients with hospitalised COVID-19, 2.96% with non-hospitalised COVID-19, and 2.61% in those without COVID-19.
  • AIS patients with a history of hospitalised COVID-19 had 1.62 times greater VTE prevalence compared to those without COVID-19.
  • AIS patients with a history of non-hospitalised COVID-19 had 1.13 times greater VTE prevalence compared to those without COVID-19.

Conclusions:

  • A significantly higher prevalence of VTE exists among Medicare beneficiaries with AIS and a history of COVID-19.
  • Early identification of coagulation abnormalities in these patients is crucial.
  • Prompt and appropriate interventions may improve clinical outcomes for AIS patients with COVID-19 history.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
16
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
31
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
24
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
26
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
26